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Abstract
Amid provider reports of financial barriers as an impediment to adult immunization, this study 
explores the time and costs of vaccination in adult provider practices. Both a Vaccination Time-
Motion Study and Vaccine Practice Management Survey were conducted (March – October 2017) 
in a convenience sample of 19 family medicine (FM), internal medicine (IM), and obstetrician-
gynecology (OBGYN) practices, in nine states. Practices were directly observed during a one 
week period; estimates were collected of time spent on activities that could not be directly 
observed. Cost estimates were calculated by converting staff time for performed activities. In the 
time-motion study, FM and IM practices spent similar time conducting vaccination activities 
(median = 5 min per vaccination), while OBGYN practices spent more time (median = 29 min per 
vaccination). Combining results from the time-motion study and the practice management survey, 
the median costs of vaccination remained similar for FM practices and IM practices at $7 and $8 
per vaccination, respectively, but was substantially higher for OBGYN practices at $43 per 
vaccination. Factors that contributed to higher costs among OBGYN practices were the increased 
time to counsel patients, administer vaccines, and to plan and manage vaccine supplies. In 
addition, 68% of OBGYN patients who were offered and counseled to receive vaccines declined to 
receive them. Counseling patients who ultimately do not go on to receive a vaccine may be an 
important cost factor. Lower costs of vaccination services may be achieved by increasing 
efficiencies in workflow or the volume of vaccinations.
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1. Introduction
Vaccination coverage among adults remains low in the United States [1]. Provider 
recommendations are a key factor for increasing adult vaccination coverage [2]. Concerted 
efforts to increase provider implementation of the National Vaccine Advisory Committee 
(NVAC) Standards for Adult Immunization [3] places even greater emphasis on 
understanding the time and cost drivers related to vaccinating practices. Although providers 
support the benefits of adult vaccination, they also report several barriers including the costs 
of providing vaccination services, competing demands to deliver acute medical care as well 
as other preventive services, the complexity of the recommended adult immunization 
schedule, and challenges with electronic health records and state immunization information 
systems [4,5].
There are a few studies that have documented the costs of providing child vaccinations [6–
8], but little is known about the financial impact of adult immunizations on practices outside 
of influenza vaccination [9]. Adult providers are concerned about purchasing vaccines and 
potential financial losses related to public or private health insurance coverage, which can 
impact their ability to provide vaccination services [9–10]. Additionally, providers in large 
medical group practices or health systems may experience lower costs of vaccination 
services due to efficiencies gained through the health system such as the centralization of 
administrative or billing services, or other efficiencies [11]. Patient perceptions also affect 
time providers spend on counseling, which may not lead to patient receipt of vaccine. 
Finally, the current procedural codes for immunization administration do not capture time 
physicians spend on addressing questions and concerns of patient who ultimately choose not 
to vaccinate. In two reports [10,12], the NVAC recommended other billing codes may be 
appropriate to use for time spent on vaccine counseling when a vaccine is not ultimately 
given. This study aims to better understand the time and costs for vaccination activities in 
adult provider practices and to potentially improve efficiencies in provider practices or 
support a rationale for non-vaccinating providers to begin offering vaccination services.
2. Methods
2.1. Data collection
Initial recruitment began in four cities from four states. Selection of these cities was based 
on the distribution of wages for medical professionals with two cities from the top tertile and 
two from the bottom tertile [13]. The focus on wages for medical professional is reasonable 
given that a major objective of this study was to calculate the value of time spent during 
interactions between patients and medical professionals. A web-based search, using Google 
Maps, of each city was used to identify potential FM, IM, and OBGYN practices to recruit. 
Across the four cities, more than 250 practices were first contacted via a postal letter and 
then with a phone call. Practices were considered eligible for inclusion if the practice 
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provided 5 or more vaccinations per week in order to allow for the inclusion of smaller 
practices that may administer few vaccinations. Low response rates were experienced 
following the initial recruitment activities, particularly among OBGYN practices. This led to 
the use of the American College of Obstetricians and Gynecologists (ACOG) professional 
directory to identify additional OBGYN practices to recruit. Continued low response rates 
from practices identified with the OBGYNs professional directory eventually led to the use 
of a recruitment sample from a separate, unrelated study being conducted by RTI 
International, which resulted in the addition of 5 OBGYN practices to our study. The 
cumulative recruitment efforts resulted in a convenience sample of 19 practices from nine 
states. This study was conducted from March to October 2017, and included a one-week 
long timemotion study and a one-time practice management survey. In the Time-Motion 
Study, data collectors observed and recorded the times of vaccination activities in a practice. 
Practice staff that participated in the Time-Motion Study were given $50 gift cards in 
appreciation of their participation. The RTI International Institutional Review Board (IRB) 
determined this study was not human subjects research because data was only collected on 
the time spent on activities and no information was collected about individuals.
2.2. Vaccination time-motion study protocol
Trained data collectors were stationed at each practice for one week to directly observe 
practice staff conduct six vaccination- related activities on a per adult patient basis. Time 
spent on activities were recorded in minutes and seconds. These activities were:
1. Additional review of patient record for vaccination status including discussion 
with the patient. The initial assessment of immunization status based on chart 
review was determined in advance of patient appointment and captured in the 
Management Survey.
2. Provider counseling
3. Preparation of vaccine
4. Preparation of patient, vaccine administration, and disposal of waste
5. Documentation in the patient record
6. Post-vaccination direct patient observation for adverse reaction (if indicated by 
standard of practice). This only included time staff spent checking on the patient.
Practice staff identified patients eligible for vaccination based on chart review before the 
visit and were instructed to inform the data collector when vaccination-related activities 
were to begin. After receiving patient consent, practice staff invited the data collector to 
observe the vaccination-related portions of the visit regardless of visit type (e.g., sick visit, 
annual wellness visit). Data collectors were only present for the vaccination portion of the 
visit, so if the provider restarted vaccination counseling at a later point in the visit, the data 
collector would not have captured that time. We did not have an indication that this occurred 
during data collection. If multiple patients undergoing vaccination-related activities at the 
same time, the data collector could only follow one patient and followed the first patient 
available. Data collectors recorded the type of professional staff (i.e., nurse, nurse 
practitioner, physician assistant, physician) performing each activity. Each activity was 
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recorded as performed by only one staff member. In general, activities observed in the time-
motion study were not assessed using the practice management survey. One exception was 
the assessment of the immunization status of patients, which occasionally occurred at two 
different points in the vaccination service workflow. Most patient immunization statuses 
were initially assessed in weekly or daily activities of the practice, while the patient was not 
present, but in some cases, there was additional review of patient need for vaccination at 
patient intake through discussion with the patient.
2.3. Vaccine practice management survey
The practice management survey was an electronic survey sent to practice managers, 
managing physicians, or administrative managers in practices to self-report time spent by 
staff type (e.g., practice manager, nurse, physician’s assistant, physician) on six activities:
1. Review of patient record to assess immunization
2. Forecasting demand and ordering vaccines
3. Managing inventory, including taking stock of inventory and monitoring 
refrigerators and freezers
4. Staff training and education
5. Billing for vaccine and vaccination services
6. Entry into state immunization information systems.
For all activities, respondents were instructed to report average weekly hours. Practices also 
reported the number of patients vaccinated during the week of the survey and the time-
motion study. In some cases, particularly in larger practices, data collectors were frequently 
unable to observe all vaccinations that occurred in the practice during the week.
2.4. Data entry and quality control
In the time-motion study, data was collected using a tablet computer application designed for 
this study. The data collector started and stopped the timer in the application when an 
activity began and finished. The application stored the times for each activity for each 
patient. The study included five data collectors. Because of concerns over potential 
differences in data collector interpretation of activities, a detailed training was conducted 
prior to the start of the data collection period. Additionally, after data collection, the data 
was reviewed for overall quality. In cases where there was overlap in activities performed by 
practice staff, the data collector recorded all time as one activity. For example, if a nurse 
provided counseling on vaccination while preparing the patient, the two activities would be 
recorded together, because the data collection application could only record one activity at a 
time. In addition, in some cases vaccine preparation may occur for patients who may be 
indicated for vaccination but go on to decline vaccination during the visit.
2.5. Analysis
Vaccination Time-Motion Study—Time and cost estimates were reported as median, 
minimum, and maximum minutes observed per patient and stratified by practice type. Due 
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to the small sample size in our study, one or two outlier values can have a substantial 
influence on the estimated mean. In this study, the median values are considered a better 
representation of the time and cost values that would be experienced at a typical provider’s 
office.
When analyzing the time-motion study data, we combined the time and costs related to the 
following activities: Provider Counseling, Preparation of Vaccine, Preparation of Patient, 
Vaccine Administration, and Disposal of Waste, and Post-Vaccination Direct Patient 
Observation. These activities were performed simultaneously or in such quick succession 
that the data collector could not reliably record them as separate activities.
Vaccine Practice Management Survey—The median, minimum, and maximum values 
of weekly self-reported times by survey respondents were reported. In the practice 
management survey, to estimate time per vaccine we divided the weekly time by the weekly 
number of patients receiving a vaccination. In the survey, practice managers only reported 
the number of patients receiving a vaccination during the week. Since very few (<5%) 
patients received more than one vaccine in the time-motion study, we assume that the 
number of patients receiving vaccines is equal to the number of vaccines administered. Two 
practices did not disclose the number of vaccinated patients in a week in their practice 
management survey, for these two practices we used the number of vaccinations observed 
during the time-motion study.
Costs—Cost estimates were calculated by converting all staff time reported (i.e., OBGYN, 
general physicians, nurses, nurse practitioners, physician assistants, medical secretaries, 
managers, and pharmacists) for each activity using mean wage data by city [13] and 
adjusting for average fringe benefits [14]. For non-labor storage costs in the practice 
management survey, weekly costs were computed by dividing the cost of purchasing storage 
equipment by the number of weeks practices reported using this equipment before 
replacement. Costs of related vaccination supplies (i.e., syringes) were not requested, but 
based on a published source [9] All costs were adjusted for inflation to 2017 dollars [15].
3. Results
The time-motion study was completed by 19 practices and two community-based 
pharmacies, but patient vaccinations were only able to be observed in 16 practices. The 
practice management survey was completed by 17 of 19 practices and 16 practices 
completed both components. Table 1 presents characteristics of the practices in the sample 
including their state, practice type, size, whether they are part of a health system, and what 
vaccines were observed as part of the time motion study. The majority of practices were 
classified as large (13 practices) and were part of a health system (13 practices).
We observed 451 patients in the time-motion study. While all 451 were indicated for a 
vaccination, 248 (55%) did not receive a vaccination, 190 (42%) received one vaccination, 
and 13 (3%) received two vaccinations. Similar amounts of time were recorded for FM and 
IM practices, but OBGYN practices spent more time on all vaccination-related activities 
(Table 2). Across all practice types, the majority of time was spent on the combined 
Shen et al. Page 5
Vaccine. Author manuscript; available in PMC 2019 November 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
activities of: Provider Counseling, Preparation of Vaccine, Preparation of Patient and 
Administration, Disposal, and Post-Vaccination Direct Patient Observation. FM and IM 
practices spent comparable median time on these activities (3:09 and 1:57 min, 
respectively), and OBGYN practices spent more (8:22 min). The FM and IM practices spent 
less median time on additional review of patient record (0:02 and 0:00 min, respectively) 
than OBGYN practices (1:10 min). In total time on directly-observed vaccination-related 
activities, FM practices spent 4:51 min (costing $4.39), IM practices spent 2:48 min ($2.33), 
and OBGYN practices spent 10:34 min ($12.06) (Table 2). Medical doctors performed 
counseling at only four of the practices in the sample. At those fours practices they 
performed 33% of counseling. At all other practices counseling was performed by nurses.
Table 3 presents results from the time-motion study stratified by patients who either did or 
did not receive a vaccination. IM practices did not spend as much time on vaccination-
related activities with patients that did not receive a vaccination in the end (0:19 min), 
relative to FM (3:20 min) and OBGYN (8:35 min). Among patients indicated for 
vaccination during the visit, the percent of patients that declined vaccination was 32% in FM 
practices, 49% in IM practices, and 69% in OBGYN practices. After including the time 
costs of patients that did not receive a vaccination, the median costs in FM and IM practices 
increased a small amount (from $4.39 to $4.54 and from $2.33 to $4.06, respectively), but 
costs in OBGYN practices increased more substantially (from $12.06 to $25.89).
Results from the practice management survey show FM practices had a lower median time 
per vaccine on each activity and OBGYN practice spent the most time on each activity 
except for review of patient records (Table 4). The median total time per vaccine on 
management activities was small for FM and IM practices (33:21 and 6:23 min, 
respectively) and higher for OBGYN practices (41.30 min) (Table 4).
Table 5 presents estimates of the total time and associated costs of all vaccination related 
activities on a per vaccine basis, combining estimated costs from the time-motion study and 
the practice management survey. Reported time and costs are stratified into two groups, one 
group includes costs of vaccinated patients only and the other includes costs of both 
vaccinated and unvaccinated patients. Looking at vaccinated patients only, the median costs 
were comparable between FM and IM practices ($6.94 and $7.23, respectively), but higher 
for OBGYN practices ($36.04). Including time spent with both vaccinated and unvaccinated 
patients increases the median time for FM practices ($0.15 increase), for IM practices ($0.81 
increase), and for OBGYN practices ($6.61 increase). When reviewing the reported costs of 
“vaccinated patients only” versus the costs of “vaccinated and unvaccinated patients” among 
OBGYN, the difference is modest in this table relative to the difference reported in Table 3. 
This disparity between Table 5 and Table 3 is because our primary analytic statistic is the 
median.
4. Discussion
This study observed a broad range in the estimated time and cost burden of health care 
providers, who provide immunization services to adult patients. All the patients included in 
the timemotion study were indicated to receive a vaccination. However, a substantial portion 
Shen et al. Page 6
Vaccine. Author manuscript; available in PMC 2019 November 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
of these patients chose not to receive a vaccination after time spent counseling, with the 
highest rate of non-vaccination after counseling among OBGYN practices (69%). Little data 
is available documenting the prevalence of vaccine refusal by adults, but this estimate is 
substantially higher than one previous study of influenza and pneumococcal vaccine refusal 
by older adults (aged ≥ 65) [16]. This higher estimate may be because our study examined 
non-influenza vaccines, which adults may be more likely to refuse, included adults under 
age 65 who may be more likely to refuse vaccination, and included OBGYN practices where 
patients may not feel inclined to receive a vaccination. Counseling patients who do not go on 
to receive vaccines can bring substantial costs to the practice that may not be reimbursable 
depending on OBGYN billing practices. This may warrant further exploration and education 
on how to bill for this counseling utilizing evaluation and management codes and, if 
appropriate, for the type of visit. Additionally, it would be beneficial to explore methods for 
providers to overcome patient vaccine refusal. Practices spent less time with patients that did 
not go on to receive a vaccination, which may indicate that patients did not receive the most 
effective counseling. This is most notable in IM practices where staff spent a median time of 
just 19 s with patients that did not receive a vaccination. One might expect that staff would 
need to spend more time with a patient that initially refused vaccination in order to convince 
them of the benefits of vaccination. Therefore, low times spent with patients that did not 
receive a vaccination may indicate that more time and more effective messaging should be 
used for these patients. Data were not collected on the type of visit and other services that 
may have been provided during the patient visit. The quality of counseling was not assessed 
in this study and may be an area of future research. The proportion of patients who receive 
counseling and do not go on to receive vaccines may also be widely varied. While this study 
included a small sample of provider practices, this data may serve as a preliminary basis for 
the exploration of a counseling code without a service that has been utilized for other 
preventive services such as tobacco cessation counseling for adults and adolescents code 
[17].
We generally observed that FM and IM practices spend approximately the same time 
vaccinating adults, but that OBGYN practices spent substantially more time on vaccination. 
This may be because FM and IM practices have more automated processes in place due to 
their traditional role as vaccination providers while OBGYN practices may not yet have 
these processes, because in many cases vaccination has not traditionally been part of the 
services they offered. Additionally, implementation of standing orders may lead to reduced 
time on vaccination.
We observed that FM providers spend much less time in activities leading up to the actual 
vaccination on a per vaccination basis. FM providers may benefit from some economies of 
scale (i.e., administering more vaccinations leads to a lower average cost per vaccination) 
because the overall volume of vaccinations provided in FM settings can include a large 
number of pediatric vaccines. Economies of scale occur because certain fixed costs, such as 
ordering vaccines and storage of vaccines, do not vary as much with the number of vaccines, 
administering more vaccines can lead to lower average time and costs per vaccine 
administered. This highlights the importance of effectively identifying patients in need of 
vaccination in order to increase the number of recommended vaccinations in the practice’s 
patient population. Moreover, for practices operating within a health system, some of the 
Shen et al. Page 7
Vaccine. Author manuscript; available in PMC 2019 November 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
fixed costs associated with vaccination may be absorbed by other departments within the 
health system, leading to cost efficiencies for those practices. Within the study sample, 81% 
of providers reported they were a part of a larger health system and the majority reported 
zero costs to the practice of administrative activities such as billing and interfacing with the 
IIS. Better understanding of the time providers spend conducting each vaccination activity 
provides information that can be used by providers to better manage and improve their 
vaccination services workflow.
This study had a number of limitations. First, the practices included in the sample are not 
generalizable to the broader population of practices providing adult vaccination. 
Recognizing provider practices and types vary widely, we emphasize that this study included 
a limited sample of providers. Additionally, most of the data were collected outside of 
influenza season, a period of time when the volume of vaccinations in practices dramatically 
increases. Both FM and OBGYN practices observed during the influenza season included a 
higher number of vaccinations as compared to practices outside of influenza vaccination 
season. Vaccination during influenza season may dramatically change the estimates 
collected in this study by increasing volume and possible decreasing spent on each activity 
due to a more streamlined approach to influenza vaccination. Further, the study may 
underestimate the time and costs required for management activities as well as those that 
may be incurred at the group level that would otherwise be incurred by the practice. Finally, 
in the time-motion study, certain activities during a patient’s appointment may or may not 
have been explicitly initiated or completed. As a result, data collectors used their best 
judgement to decide when an activity was initiated or completed. This may have resulted in 
mis-characterization of a small portion of time and activities. This kind of potential mis-
characterization would not be likely to have a substantial qualitative impact on our broader 
findings about the total costs of providing vaccination or the importance of patients who 
decline to receive vaccines. Additionally, the data collector could not observe the counseling 
activity if physicians recommended vaccination and provided counseling while conducting 
another activity in the visit where the data collector is not present (e.g. physical exam), 
which would lead to an underestimate of counseling time. It is important to note that the 
total time and costs in the direct observation time-motion study for IM practices are 
underestimated as provider counseling for IM was aggregated into other activities (Table 2) 
that were not ascribed the higher (e.g., physician or nurse practitioner) wage rates.
5. Conclusion
Adult vaccine providers should consider the volume of vaccinations and fixed costs as an 
important factor affecting total cost per vaccination. Practices can take advantage of the 
economies of scale associated with fixed administrative costs by increasing the number of 
recommended vaccinations they administer to their patients.
Another important factor for practices to consider is resources spent on patients who are 
considered for vaccination, but do not receive a vaccination. If providers cannot bill for this 
time, then time spent counseling without vaccination can drive up costs. It is therefore 
important for practices to utilize effective counseling methods and increase the uptake of 
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vaccinations for counseled patients. Considering these approaches can help practices to 
increase the financial stability of vaccination at their practice.
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Table 5
Median total costs from the vaccination time-motion and vaccine practice management survey.
Practice Type Median Total Cost, including only vaccinated patients 
$vaccine administered
Median Total Cost, including vaccinated and unvaccinated 
patients $/vaccine administered
FM (n = 5) $6.94 ($2.22 – $19.64) $7.09 ($3.88 – $24.14)
IM (n = 4) $7.23 ($5.41 – $118.81) $8.04 ($5.41 – $121.84)
OBGYN (n = 6) $36.04 ($17.56 – $91.08) $42.65 ($25.79 – $280.28)
Source Notes: Minimum and maximum values are noted in parentheses.
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